期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 31 ()
Objectives: Dabigatran has a better safety profile and requires less monitoring, but is costlier than warfarin. This study evaluated the cost-utility ......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 32 ()
Objectives: This study aimed to estimate the epidemiologic and economic impact of a nonavalent human papillomavirus (HPV) vaccination program for 13- ......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 27 ()
Objectives: To date, there has been scant research on patient input regarding the desirable characteristics of healthcare facilities. This study uses ......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 28 ()
Objectives: The purpose of this study was to evaluate the cost-effectiveness of nab-paclitaxel and gemcitabine (GnP) compared with gemcitabine monothe......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 30 ()
Objectives: This study aimed to determine the prevalence and associated factors of out-of-pocket pharmaceutical expenditure (OOPPE) among primary heal......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 30 ()
Objectives: Lung cancer imposes a significant economic burden on most countries. Nevertheless, there is scarce information about this burden on health......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 29 ()
Objectives: There has been a growing interest in the use of EQ-5D health outcomes measures in Latin America and the Caribbean. Population norms data p......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 31 ()
Objectives: This study aimed to determine the cost-effectiveness of drug-coated balloon (DCB) angioplasty compared with conventional balloon angioplas......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 27 ()
Objectives: To assess the cost-effectiveness of varenicline in comparison to currently funded smoking cessation strategies in Brazil. Methods: We mode......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 30 ()
Objectives: This study aimed to investigate the willingness to pay (WTP) for a hypothetical vaccine and its associated determinants among the Lebanese......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 28 ()
Objectives: To examine the budget impact of emicizumab as prophylactic therapy in reducing the frequency of bleeding episodes in patients with hemophi......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 28 ()
Objectives: Azathioprine has been the therapy of choice for the maintenance of remission in patients with antineutrophil cytoplasm antibody (ANCA)-ass......
期刊： VALUE IN HEALTH REGIONAL ISSUES, 2022; 31 ()
Objectives: Several trials have demonstrated the benefit of the CDK 4/6 inhibitors for postmenopausal women with luminal advanced breast cancer. This ......
